3,4-dihydroxybenzohydroxamic acid has been researched along with Fibroma, Shope in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, appeal for the long-term use of HU in HIV-1 infection may be limited by its propensity to induce hematopoietic toxicity." | 1.31 | Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea. ( Ahmed, MM; Chendil, D; Elford, HL; Gallicchio, VS; Greenberg, RN; Mampuru, LJ; Mayhew, CN; Phillips, JD, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayhew, CN | 2 |
| Mampuru, LJ | 1 |
| Chendil, D | 1 |
| Ahmed, MM | 1 |
| Phillips, JD | 2 |
| Greenberg, RN | 1 |
| Elford, HL | 2 |
| Gallicchio, VS | 2 |
| Sumpter, R | 1 |
| Inayat, M | 1 |
| Cibull, M | 1 |
2 other studies available for 3,4-dihydroxybenzohydroxamic acid and Fibroma, Shope
| Article | Year |
|---|---|
Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
Topics: Animals; Benzamidines; Bone Marrow Cells; DNA, Viral; Female; Femur; Free Radical Scavengers; Hemato | 2002 |
Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Topics: Animals; Antiviral Agents; B-Lymphocytes; Benzamidines; Didanosine; Drug Therapy, Combination; Enzym | 2005 |